These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28883402)

  • 1. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
    McBride A; Hoy AM; Bamford MJ; Mossakowska DE; Ruediger MP; Griggs J; Desai S; Simpson K; Caballero-Hernandez I; Iredale JP; Pell T; Aucott RL; Holmes DS; Webster SP; Fallowfield JA
    Sci Rep; 2017 Sep; 7(1):10806. PubMed ID: 28883402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
    Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
    Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of small-molecule agonists of human relaxin family receptor 1 (RXFP1) by using a homogenous cell-based cAMP assay.
    Chen CZ; Southall N; Xiao J; Marugan JJ; Ferrer M; Hu X; Jones RE; Feng S; Agoulnik IU; Zheng W; Agoulnik AI
    J Biomol Screen; 2013 Jul; 18(6):670-7. PubMed ID: 23212924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.
    Kaftanovskaya EM; Ng HH; Soula M; Rivas B; Myhr C; Ho BA; Cervantes BA; Shupe TD; Devarasetty M; Hu X; Xu X; Patnaik S; Wilson KJ; Barnaeva E; Ferrer M; Southall NT; Marugan JJ; Bishop CE; Agoulnik IU; Agoulnik AI
    FASEB J; 2019 Nov; 33(11):12435-12446. PubMed ID: 31419161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
    Agoulnik AI; Agoulnik IU; Hu X; Marugan J
    Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists.
    Granberg KL; Sakamaki S; Fuchigami R; Niwa Y; Fujio M; Kato H; Bergström F; Larsson N; Persson M; Villar IC; Fujita T; Sugikawa E; Althage M; Yano N; Yokoyama Y; Kimura J; Lal M; Mochida H
    J Med Chem; 2024 Mar; 67(6):4442-4462. PubMed ID: 38502780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.
    Wilson KJ; Xiao J; Chen CZ; Huang Z; Agoulnik IU; Ferrer M; Southall N; Hu X; Zheng W; Xu X; Wang A; Myhr C; Barnaeva E; George ER; Agoulnik AI; Marugan JJ
    Eur J Med Chem; 2018 Aug; 156():79-92. PubMed ID: 30006176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
    Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
    Nat Commun; 2013; 4():1953. PubMed ID: 23764525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.
    Huang Z; Myhr C; Bathgate RA; Ho BA; Bueno A; Hu X; Xiao J; Southall N; Barnaeva E; Agoulnik IU; Marugan JJ; Ferrer M; Agoulnik AI
    Front Endocrinol (Lausanne); 2015; 6():128. PubMed ID: 26347712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models.
    Illiano S; Poirier B; Minoletti C; Pasquier O; Riva L; Chenede X; Menguy I; Guillotel M; Prigent P; Le Claire S; Gillot F; Thill G; Lo Presti F; Corbier A; Le Bail JC; Grailhe P; Monteagudo E; Ingenito R; Bianchi E; Philippo C; Duclos O; Mallart S; Bathgate R; Janiak P
    Sci Rep; 2022 Nov; 12(1):20435. PubMed ID: 36443381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design.
    D'Ercole A; Nistri S; Pacini L; Carotenuto A; Santoro F; Papini AM; Bathgate RAD; Bani D; Rovero P
    Front Pharmacol; 2022; 13():942178. PubMed ID: 36034864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.
    Ng HH; Esteban-Lopez M; Agoulnik AI
    Mol Cell Endocrinol; 2019 May; 487():40-44. PubMed ID: 30590098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin in hepatic fibrosis: What is known and where to head?
    Ezhilarasan D
    Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
    Hossain MA; Wade JD; Bathgate RA
    Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R2R01: A long-acting single-chain peptide agonist of RXFP1 for renal and cardiovascular diseases.
    Poirier B; Pasquier O; Chenede X; Corbier A; Prigent P; Azam A; Bernard C; Guillotel M; Gillot F; Riva L; Briand V; Ingenito R; Gauzy-Lazo L; Duclos O; Philippo C; Maillere B; Bianchi E; Mallart S; Janiak P; Illiano S
    Br J Pharmacol; 2024 Jul; 181(13):1993-2011. PubMed ID: 38450758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290.
    Kaftanovskaya EM; Soula M; Myhr C; Ho BA; Moore SN; Yoo C; Cervantes B; How J; Marugan J; Agoulnik IU; Agoulnik AI
    J Endocr Soc; 2017 Jun; 1(6):712-725. PubMed ID: 28825052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.
    Kern A; Bryant-Greenwood GD
    Endocrinology; 2009 May; 150(5):2419-28. PubMed ID: 19116340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.